AstraZeneca lupus drug succeeds in trial as COPD therapy fails
(Alliance News) - AstraZeneca PLC on Wednesday reported mixed updates from its late-stage pipeline, with a lupus treatment hitting its main goal in a phase III trial, while a chronic obstructive pulmonary disease candidate fell short. Read More